Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$284M |
| 2 |
FISV
Fiserv Inc
FISV
|
+$232M |
| 3 |
Alibaba
BABA
|
+$183M |
| 4 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$123M |
| 5 |
Oracle
ORCL
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$287M |
| 2 |
JD.com
JD
|
+$168M |
| 3 |
Take-Two Interactive
TTWO
|
+$117M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$116M |
| 5 |
Applied Materials
AMAT
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.9% |
| 2 | Technology | 20.77% |
| 3 | Consumer Discretionary | 14.79% |
| 4 | Financials | 9.69% |
| 5 | Industrials | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
TSMC
TSM
$2.17T
| $5.9M | 0.04% |
104,000
-430,632
| -81% | -$22.7M |
|
|
ACH
452
Accendra Health
ACH
$92.3M
| $5.89M | 0.04% |
773,051
+700,551
| +966% | +$5.13M |
|
453
Ashland
ASH
$3.33B
| $5.82M | 0.04% |
+84,153
| New | +$5.22M |
|
|
454
Micron Technology
MU
$1.09T
| $5.8M | 0.04% |
112,500
-6,093,925
| -98% | -$287M |
|
455
AGNC Investment
AGNC
$12.9B
| $5.77M | 0.04% |
447,558
-3,183,070
| -88% | -$39.9M |
|
456
TotalEnergies
TTE
$199B
| $5.77M | 0.04% |
150,000
-998,250
| -87% | -$37M |
|
457
Keros Therapeutics
KROS
$219M
| $5.71M | 0.04% |
+152,300
| New | +$4.69M |
|
|
FL
458
DELISTED
Foot Locker
FL
| $5.69M | 0.04% |
195,214
+98,275
| +101% | +$2.6M |
|
|
INFO
459
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $5.67M | 0.04% |
+75,089
| New | +$5.11M |
|
460
JPMorgan Chase
JPM
$935B
| $5.64M | 0.04% |
+60,000
| New | +$5.69M |
|
461
DTE Energy
DTE
$28.1B
| $5.63M | 0.04% |
61,570
+43,122
| +234% | +$3.82M |
|
|
MIC
462
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $5.61M | 0.04% |
182,693
+137,427
| +304% | +$3.8M |
|
|
LBRDK
463
DELISTED
Liberty Broadband Class C
LBRDK
| $5.58M | 0.04% |
+45,000
| New | +$5.65M |
|
464
CALL
Teva Pharmaceuticals
TEVA
$43.5B
| $5.55M | 0.04% |
+450,000
| New | +$5.09M |
|
|
VIE
465
DELISTED
Viela Bio, Inc. Common Stock
VIE
| $5.54M | 0.04% |
+127,983
| New | +$5.8M |
|
466
Brinker International
EAT
$10.6B
| $5.5M | 0.04% |
+229,034
| New | +$4.91M |
|
467
Conagra Brands
CAG
$7.89B
| $5.48M | 0.04% |
+155,739
| New | +$5.19M |
|
468
Urban Outfitters
URBN
$6.36B
| $5.45M | 0.04% |
357,967
-150,547
| -30% | -$2.58M |
|
469
Option Care Health
OPCH
$3.55B
| $5.38M | 0.04% |
+387,705
| New | +$5.13M |
|
470
Timken Company
TKR
$8.67B
| $5.37M | 0.04% |
+118,054
| New | +$4.66M |
|
471
The Mosaic Company
MOS
$7.76B
| $5.31M | 0.03% |
424,300
+228,600
| +117% | +$2.74M |
|
|
GOOS
472
Canada Goose Holdings
GOOS
$854M
| $5.28M | 0.03% |
+227,729
| New | +$5.06M |
|
473
CALL
State Street SPDR S&P Homebuilders ETF
XHB
$1.46B
| $5.27M | 0.03% |
+120,000
| New | +$4.56M |
|
|
AAWW
474
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $5.24M | 0.03% |
121,856
-189,017
| -61% | -$6.63M |
|
|
SAGE
475
DELISTED
Sage Therapeutics
SAGE
| $5.12M | 0.03% |
+123,134
| New | +$4.47M |
|
Similar funds
Steven Cohen's Q2 2020 Portfolio in Review
As of Q2 2020, Steven Cohen held 1,113 positions worth $15.3B, up 25% from $12.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Steven Cohen's Q2 2020 filing shows 368 new, 189 increased, 211 reduced and 335 closed positions. Its largest new stake was Merck: 3,769,218 shares worth $278M. The largest sale was Micron Technology, an estimated $287M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- Steven Cohen's largest Q2 2020 buy was Merck: 3,769,218 shares worth $278M.
- Steven Cohen added most to Fiserv Inc in Q2 2020, an estimated $232M increase.
- Steven Cohen's biggest Q2 2020 reduction was Micron Technology, cutting an estimated $287M.
- Steven Cohen fully exited CSX Corp in Q2 2020, selling an estimated $110M.
- Steven Cohen's ten largest holdings make up 16% of its $15.3B portfolio in Q2 2020.
- Steven Cohen opened 368 new positions and closed 335 in Q2 2020.
- Steven Cohen's portfolio value rose 25% quarter-over-quarter to $15.3B.
Based on Point72 Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.